Toggle navigation
Home
Search
Services
Blog
Contact
About
Development of Human Megakaryocyte Progenitor Assay
Murphy, Martin J.
Hipple Cancer Research Corporation, Dayton, OH, United States
Search 58 grants from Martin Murphy
Search grants from Hipple Cancer Research Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
A Team Model of Hypertension Care in African Americans
Immune Activation of Nk and Tumor Specific T Cells by IN
Reflex Action of Muscle Contraction
Clinical Research Center - Clinical Associate Physician
Mapping Melt and Matrix Flow in the Uppermost Mantle: Undershooting the East Pacific Rise between Siqueiros and Clipperton
Recently added grants:
Topiramate Treatment of Alcohol Use Disorder in African Americans
Imaging retinal leukocyte-endothelial interaction as a diagnostic marker for multiple sclerosis
Family-based eHealth Obesity Prevention Intervention for Hispanic Adolescents
Itch Ubiquitin Ligase and Germinal Center B cells
Wearable sensor for passive detection and efficient treatment of multiple disorders
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44AI034817-03
Application #
2070001
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1993-09-01
Project End
1997-07-31
Budget Start
1996-01-01
Budget End
1997-07-31
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Hipple Cancer Research Corporation
Department
Type
DUNS #
City
Dayton
State
OH
Country
United States
Zip Code
45439
Related projects
NIH 1996
R44 AI
Development of Human Megakaryocyte Progenitor Assay
Murphy, Martin J. / Hipple Cancer Research Corporation
NIH 1995
R44 AI
Development of Human Megakaryocyte Progenitor Assay
Murphy, Martin J. / Hipple Cancer Research Corporation
Comments
Be the first to comment on Martin Murphy's grant